Evidence map›Paper›PMID 40119381›Full record

ArticleParasites & vectors2025

Prevalence of anti-Trypanosoma cruzi and anti-Leishmania infantum antibodies in domestic dogs from Tremedal, Bahia: insights from the Oxente Chagas Bahia Project.

Tycha Bianca Sabaini Pavan, Larissa Carvalho Medrado Vasconcelos, Isabela Machado Serrano, Denis Augusto Argolo Campos, Ângelo Antônio Oliveira Silva, Randrin Queiroz Viana Ferreira, Daniel Dias Sampaio, Isadora Cristina de Siqueira, Fred Luciano Neves Santos

Abstract read
In one paragraph

Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tycha Bianca Sabaini PavanAdvanced Public Health Laboratory, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Bahia, Brazil.
Larissa Carvalho Medrado VasconcelosAdvanced Public Health Laboratory, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Bahia, Brazil.
Isabela Machado SerranoAdvanced Public Health Laboratory, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Bahia, Brazil.
Denis Augusto Argolo CamposAdvanced Public Health Laboratory, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Bahia, Brazil.
Ângelo Antônio Oliveira SilvaAdvanced Public Health Laboratory, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Bahia, Brazil.
Randrin Queiroz Viana FerreiraAdvanced Public Health Laboratory, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Bahia, Brazil.
Daniel Dias SampaioInterdisciplinary Research Group in Biotechnology and Epidemiology of Infectious Diseases (GRUPIBE), Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Bahia, Brazil.
Isadora Cristina de SiqueiraInterdisciplinary Research Group in Biotechnology and Epidemiology of Infectious Diseases (GRUPIBE), Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Bahia, Brazil.
Fred Luciano Neves SantosAdvanced Public Health Laboratory, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Bahia, Brazil. fred.santos@fiocruz.br.

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 117618/2022-5Conselho Nacional de Desenvolvimento Científico e Tecnológico 166517/2022-4Conselho Nacional de Desenvolvimento Científico e Tecnológico 306448/2023-8Conselho Nacional de Desenvolvimento Científico e Tecnológico 316456/2021-7Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88887.637869/2021-00Coordenação de Aperfeiçoamento de Pessoal de Nível Superior Finance Code 001Foundation for Research Promotion of the State of Bahia (FAPESB) BOL0543/2020Foundation for Research Promotion of the State of Bahia (FAPESB) BOL0718/2022Inova Fiocruz Program VPPCB-001-FIO-22-2-11
6 · The paper itself

Abstract

backgroundChagas disease (CD) and visceral leishmaniasis (VL) are two important zoonotic diseases that present significant public health challenges in Latin America. Domestic dogs, due to their close contact with humans, serve as key reservoirs for both Trypanosoma cruzi (the causative agent of CD) and Leishmania infantum (the causative agent of VL), making them important sentinels in disease surveillance. This study, conducted as part of the Oxente Chagas Bahia Project, aimed to assess the seroprevalence of anti-T. cruzi and anti-L. infantum antibodies in domestic dogs from Tremedal, Bahia, Brazil.

methodsSerum samples from 17 dogs were analyzed using indirect enzyme-linked immunosorbent assay (ELISA) (using recombinant antigens (IBMP-8.1, IBMP-8.2, IBMP-8.3, IBMP-8.4) for T. cruzi and the TR DPP® rapid test and ELISA for L. infantum.

resultsThe results showed that 5.9% (1/17) of the dogs tested were seropositive for T. cruzi, indicating the presence of the parasite in the region. Similarly, 5.9% (1/17) of the dogs were confirmed to be positive for L. infantum by ELISA, although the results of the TR DPP® test initially suggested a higher prevalence (41.2%), highlighting the risk of false-positive results.

conclusionsThese findings underscore the critical role of dogs in CD and VL surveillance, given their involvement in both domestic and peridomestic transmission cycles. The study also emphasizes the need for confirmatory testing to ensure diagnostic accuracy, which will contribute to more effective disease control strategies in endemic areas. This work highlights the importance of a One Health approach in which human and animal health are closely monitored to mitigate the transmission of zoonotic diseases.

Indexed as

Antibodies, ProtozoanChagas DiseaseDog DiseasesLeishmania infantumLeishmaniasis, VisceralTrypanosoma cruziAnimalsBrazilDogsEnzyme-Linked Immunosorbent AssayFemaleMalePrevalenceSeroepidemiologic StudiesAntibodies, ProtozoanChagas diseaseDogsLeishmania infantumOne HealthTrypanosoma cruziVisceral leishmaniasisZoonosis

Identifiers

PMID40119381
PMCPMC11929362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.